Log in to search using one of your social media accounts:

 

American Society for Radiation Oncology Updates Insurance Coverage Recommendations for Proton Therapy

Proton beam therapy model policy recommends expanded access to advanced radiation therapy treatment for cancer patients ARLINGTON, Va., July 13, 2017 -- (Healthcare Sales &Marketing Network) -- The American Society for Radiation Oncology (ASTRO) has i... Devices, Oncology ASTRO , proton beam, proton therapy, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news

Related Links:

The use of intensity modulated proton therapy (IMPT) for the treatment of cancer has become increasingly common in recent years. The primary advantage of IMPT over intensity modulated radiation therapy with X-rays (IMRT) lies in reduction of integral dose deposited in the patient while delivering an equivalent dose to the tumour volume [1,2]. The disadvantage of proton therapy is that it is a more expensive form of treatment with limited availability.
Source: Physica Medica: European Journal of Medical Physics - Category: General Medicine Authors: Tags: Original paper Source Type: research
Radiation therapy is one of the cornerstones of contemporary cancer treatment and about 50% of patients will, at some point during their cancer history, require it. Since its first use in 1896 this therapy has evolved, following a rapid arrow of progress thanks to imaging, computing power and technical advances in delivery. Many feel that proton beam therapy, with its ability to target deep-seated tumours with less radiation exposure to the normal tissues, sits at the very tip of that arrow [1].
Source: Clinical Oncology - Category: Radiology Authors: Tags: Editorial Source Type: research
This article presents our preliminary results of a phase I study.Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume with Intensity-Modulated (Photon) Radiation Therapy or Intensity-Modulated Proton Therapy and Concurrent Chemotherapy for Stage II-III Non-Small Cell Lung Cancer: A Phase I Study
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Source Type: research
Opinion statementMost patients with hepatocellular carcinoma present with intermediate to advanced disease, where curative therapies are no longer an option. These patients with intermediate to advanced disease represent a heterogeneous population with regard to tumor burden, liver function, and performance status. While the Barcelona Clinic Liver Cancer (BCLC) staging system offers guidelines for the management of these patients, strict adherence to these guidelines may limit treatment options for these patients. Several locoregional therapies exist for these patients, including conventional transarterial chemoembolizatio...
Source: Current Treatment Options in Oncology - Category: Cancer & Oncology Source Type: research
(Northwestern Memorial HealthCare) Proton therapy treatment for prostate cancer is associated with higher survival rates and decreased risk of complications compared to intensity-modulated radiation therapy (IMRT) according to a new study by researchers at the Northwestern Medicine Chicago Proton Center.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
(Mayo Clinic) A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
(Northwestern Memorial HealthCare) The Northwestern Medicine Chicago Proton Center will host over 200 leading clinicians, physicists and researchers in the growing field of proton therapy at the 4th Annual Particle Therapy Co-Operative Group North-America (PTCOG-NA) Conference, being held Oct. 23-25, 2017 at the Swiss ô tel Chicago. Conference participants will share the latest clinical, scientific and industrial developments in particle beam therapy, an advanced form of radiation therapy using beams of protons to destroy cancer cells and diseased tissue.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Medical software and equipment company Elekta has signed separate deals with Ion Beam Applications and Brainlab to share and integrate their technologies. In the memorandum of understanding with Ion Beam Applications, the two companies agreed to collaborate on investment in software development and the sale and marketing of each other’s products through a joint portfolio. Elekta specializes in technological solutions for improving, prolonging and saving the lives of patients with cancer and brain disorders, while IBA develops solutions for the diagnosis and treatment of cancer. Specifically, the companies plan to foc...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Wall Street Beat Elekta Source Type: news
Abstract PURPOSE: To compare heart and cardiac substructure radiation exposure using intensity-modulated radiotherapy (IMRT) vs. proton beam therapy (PBT) for patients with mid- to distal esophageal cancer who received chemoradiation therapy. METHODS AND MATERIALS: We identified 727 esophageal cancer patients who received IMRT (n=477) or PBT (n=250) from March 2004 to December 2015. All patients were treated to 50.4Gy with IMRT or to 50.4 cobalt Gray equivalents with PBT. IMRT and PBT dose-volume histograms (DVHs) of the whole heart, atria, ventricles, and four coronary arteries were compared. For PBT patient...
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Tags: Radiother Oncol Source Type: research
Over the last few decades, advances in radiation therapy technology have markedly improved radiation delivery. Advancements in treatment planning with the development of image-guided radiotherapy and techniques such as proton therapy, allow precise delivery of high doses of radiation conformed to the tumor. These advancements result in improved locoregional control while reducing radiation dose to surrounding normal tissue. The radiologic manifestations of these techniques can differ from radiation induced lung disease seen with traditional radiation therapy. Awareness of these radiologic manifestations and correlation wit...
Source: Journal of Thoracic Imaging - Category: Radiology Tags: Symposium Review Articles Source Type: research
More News: Cancer | Cancer & Oncology | Insurance | Marketing | Pharmaceuticals | Proton Therapy | Radiation Therapy